EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model

Shuhei Shinoda iD, Nikita S Sharma, Naohiko Nakamura, Kazuho Inoko, Mizuho Sato-Dahlman, Paari Murugan, Julia Davydova, Masato Yamamoto

Cancer Science · 2023

DOI: 10.1111/cas.15903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Shuhei Shinoda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenoviridae Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Past clinical trials of adjuvant therapy combined with interferon (IFN) alpha, fluorouracil, cisplatin, and radiation improved the 5‐year survival rate of pancreatic ductal adenocarcinoma (PDAC). However, these trials also revealed the disadvantages of the systemic toxicity of IFN and insufficient delivery of IFN. To improve efficacy and tolerability, we have developed an oncolytic adenovirus‐expressing IFN (IFN‐OAd). Here, we evaluated IFN‐OAd in combination with chemotherapy (gemcitabine + nab‐paclitaxel) + radiation. Combination index (CI) analysis showed that IFN‐OAd + chemotherapy + radiation was synergistic (CI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalAdenoviridae InfectionsCricetinaeAnimalsHumansAdenoviridaeCell Line, TumorVirus ReplicationInterferon-alphaPaclitaxelAntineoplastic Combined Chemotherapy ProtocolsAlbumins

Stichwörter der Autor:innen

interferon alphanab-PTXoncolytic adenovirusoncolytic viruspancreatic cancer

Substanzen

Interferon-alphaPaclitaxelAlbumins

Autor:innen und Institutionen

  • Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
  • Department of Gastroenterology and Hepatology, Yamaguchi University Graduate school of Medicine, Yamaguchi, Japan.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Institute of Molecular Virology, University of Minnesota, Minneapolis, MN, USA.

ORCID-Profile: Shuhei Shinoda

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Shinoda, S., Sharma, N. S., Nakamura, N., Inoko, K., Sato-Dahlman, M., Murugan, P., Davydova, J., & Yamamoto, M. (2023). Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Cancer Science. https://doi.org/10.1111/cas.15903

Vancouver

Shinoda S, Sharma NS, Nakamura N, Inoko K, Sato-Dahlman M, Murugan P, et al. Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Cancer Science. 2023. doi:10.1111/cas.15903

BibTeX
@article{Shinoda2023,
  author = {Shinoda, Shuhei and Sharma, Nikita S and Nakamura, Naohiko and Inoko, Kazuho and Sato-Dahlman, Mizuho and Murugan, Paari and Davydova, Julia and Yamamoto, Masato},
  title = {Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15903}
}
Kostenlos starten →